Patients with non-small cell lung cancer survive longer when their therapy includes durvalumab following platinum-based chemoradiotherapy, reports a new study.
from Latest Cancer News https://ift.tt/2NK7Csa
LATEST HEALTH NEWS
Reviewed by MZ Digital Marketing Agency
on
September 29, 2018
Rating: 5
No comments
Thanks for comment via will connect you within 24 hours.
No comments
Thanks for comment via will connect you within 24 hours.